Stocks · Health care · Services-Medical Laboratories

CASTLE BIOSCIENCES INC

CSTL Clue Score48
United States Fiscal year ends December CIK 0001447362 Results filed 5 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
325
$36.81
$11.96K
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
382
$36.81
$14.06K
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan
1,025
$36.81
$37.73K
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
2,393
$36.01
$86.16K
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
2,816
$36.01
$101.39K
Derek J Maetzold
2 Nov 2026
Pres. & Chief Exec. Officer
Sold on a plan
7,555
$36.01
$272.02K
Tobin W Juvenal
28 Oct 2026
Chief Commercial Officer
Sold on a plan
5,341
$36.62
$195.58K
Tobin W Juvenal
28 Oct 2026
Chief Commercial Officer
Sold on a plan
1,237
$35.58
$44.01K
Tobin W Juvenal
26 Oct 2026
Chief Commercial Officer
Sold on a plan
3,288
$33.08
$108.77K
Derek J Maetzold
19 Oct 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
2,718
$31.91
$86.73K
Derek J Maetzold
19 Oct 2026
Pres. & Chief Exec. Officer
Sold on a plan indirect
3,198
$31.91
$102.05K
Derek J Maetzold
19 Oct 2026
Pres. & Chief Exec. Officer
Sold on a plan
8,580
$31.91
$273.79K
Tobin W Juvenal
12 Oct 2026
Chief Commercial Officer
Sold on a plan
3,288
$33.64
$110.61K

What was left out

Form 4 filings counted 6
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 31 Jul 2019